Literature DB >> 1851870

The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor.

A E Tollefson1, A R Stewart, S P Yei, S K Saha, W S Wold.   

Abstract

In adenovirus-infected cells, the epidermal growth factor receptor (EGF-R) is internalized from the cell surface via endosomes and is degraded, and the E3 10,400-dalton protein (10.4K protein) is required for this effect (C. R. Carlin, A. E. Tollefson, H. A. Brady, B. L. Hoffman, and W. S. M. Wold, Cell 57:135-144, 1989). We now report that both the E3 10.4K and E3 14.5K proteins are required for this down-regulation of EGF-R in adenovirus-infected cells. Down-regulation of cell surface EGF-R was demonstrated by results from several methods, namely the absence of EGF-R autophosphorylation in an immune complex kinase assay, the inability to iodinate EGF-R on the cell surface, the formation of endosomes containing EGF-R as detected by immunofluorescence, and the degradation of the metabolically [35S]Met-labeled fully processed 170K species of EGF-R. No effect on the initial synthesis of EGF-R was observed. This down-regulation was ascribed to the 10.4K and 14.5K proteins through the analysis of cells infected with rec700 (wild-type), dl748 (10.4K-, 14.5K+), or dl764 (10.4K+, 14.5K-) or coinfected with dl748 plus dl764. Further evidence that the 10.4K and 14.5K proteins function in concert was obtained by demonstrating that the 10.4K protein was coimmunoprecipitated with the 14.5K protein by using three different antisera to the 14.5K protein, strongly implying that the 10.4K and 14.5K proteins exist as a complex. Together, these results indicate that the 10.4K and 14.5K proteins function as a complex to stimulate endosome-mediated internalization and degradation of EGF-R in adenovirus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851870      PMCID: PMC240965     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Purification and characterization of vaccinia virus growth factor.

Authors:  P Stroobant; A P Rice; W J Gullick; D J Cheng; I M Kerr; M D Waterfield
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

2.  Identification of a novel sequence that governs both polyadenylation and alternative splicing in region E3 of adenovirus.

Authors:  H A Brady; W S Wold
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

3.  Adenovirus E1A 12S protein induces DNA synthesis and proliferation in primary epithelial cells in both the presence and absence of serum.

Authors:  M P Quinlan; T Grodzicker
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

4.  Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping.

Authors:  D A Rappolee; D Mark; M J Banda; Z Werb
Journal:  Science       Date:  1988-08-05       Impact factor: 47.728

5.  DNA sequence of the early E3 transcription unit of adenovirus 5.

Authors:  C Cladaras; W S Wold
Journal:  Virology       Date:  1985-01-15       Impact factor: 3.616

6.  Synthesis of a biological active tumor growth factor from the predicted DNA sequence of Shope fibroma virus.

Authors:  Y Z Lin; G Caporaso; P Y Chang; X H Ke; J P Tam
Journal:  Biochemistry       Date:  1988-07-26       Impact factor: 3.162

7.  Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors.

Authors:  D R Twardzik; J P Brown; J E Ranchalis; G J Todaro; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

8.  Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor.

Authors:  J P Brown; D R Twardzik; H Marquardt; G J Todaro
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

9.  Growth factor(s) produced during infection with an adenovirus variant stimulates proliferation of nonestablished epithelial cells.

Authors:  M P Quinlan; N Sullivan; T Grodzicker
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters.

Authors:  J E Morin; M D Lubeck; J E Barton; A J Conley; A R Davis; P P Hung
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

View more
  37 in total

1.  Adenovirus E3-6.7K maintains calcium homeostasis and prevents apoptosis and arachidonic acid release.

Authors:  Alexander R Moise; Jason R Grant; Timothy Z Vitalis; Wilfred A Jefferies
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus.

Authors:  H A Brady; A Scaria; W S Wold
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2.

Authors:  Drew L Lichtenstein; Konstantin Doronin; Karoly Toth; Mohan Kuppuswamy; William S M Wold; Ann E Tollefson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI.

Authors:  Jason R Grant; Alexander R Moise; Wilfred A Jefferies
Journal:  Clin Vaccine Immunol       Date:  2007-05-30

5.  Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B.

Authors:  Brian P McSharry; Hans-Gerhard Burgert; Douglas P Owen; Richard J Stanton; Virginie Prod'homme; Martina Sester; Katja Koebernick; Veronika Groh; Thomas Spies; Steven Cox; Ann-Margaret Little; Eddie C Y Wang; Peter Tomasec; Gavin W G Wilkinson
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

6.  Homologous recombination in E3 genes of human adenovirus species D.

Authors:  Gurdeep Singh; Christopher M Robinson; Shoaleh Dehghan; Morris S Jones; David W Dyer; Donald Seto; James Chodosh
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

7.  Distinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptor.

Authors:  Tom A Zanardi; Soonpin Yei; Drew L Lichtenstein; Ann E Tollefson; William S M Wold
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization.

Authors:  A Elsing; H G Burgert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

9.  Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line.

Authors:  H Körner; H G Burgert
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model.

Authors:  T E Sparer; R A Tripp; D L Dillehay; T W Hermiston; W S Wold; L R Gooding
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.